These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28164518)

  • 1. Meta-analysis: Diagnostic Value of N-Terminal Pro-brain Natriuretic Peptide for Kawasaki Disease.
    Yu J; Li HH; Dong L
    Clin Lab; 2016 Oct; 62(10):1903-1910. PubMed ID: 28164518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis.
    Lin KH; Chang SS; Yu CW; Lin SC; Liu SC; Chao HY; Lee MT; Wu JY; Lee CC
    BMJ Open; 2015 Apr; 5(4):e006703. PubMed ID: 25872939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide for Kawasaki disease: An updated systematic review and meta-analysis.
    Wen JX; Bai X; Niu Y; Hu ZD
    Int J Clin Pract; 2021 Nov; 75(11):e14538. PubMed ID: 34133819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease.
    Zheng X; Zhang Y; Liu L; Yue P; Wang C; Zhou K; Hua Y; Wu G; Li Y
    Sci Rep; 2020 Mar; 10(1):5130. PubMed ID: 32198398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
    McNeal-Davidson A; Fournier A; Spigelblatt L; Saint-Cyr C; Mir TS; Nir A; Dallaire F; Cousineau J; Delvin E; Dahdah N
    Pediatr Int; 2012 Oct; 54(5):627-33. PubMed ID: 22414326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H; Lee JH; Jung JY; Kwak YH; Kim DK; Jung JH; Chang I; Kim K
    Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A; Meloche-Dumas L; Desjardins L; Turgeon J; Saint-Cyr C; Autmizguine J; Spigelblatt L; Fournier A; Dahdah N
    Pediatr Int; 2017 Mar; 59(3):265-270. PubMed ID: 27589358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of age-adjusted N-terminal prohormone of brain natriuretic peptide level as a diagnostic marker for incomplete Kawasaki disease in children.
    Rodríguez-González M; Castellano-Martínez A; Alonso-Ojembarrena A
    Emergencias; 2019 Abr; 31(2):111-114. PubMed ID: 30963739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease.
    Rodriguez-Gonzalez M; Perez-Reviriego AA; Castellano-Martinez A; Cascales-Poyatos HM
    Biomark Med; 2019 Mar; 13(4):307-323. PubMed ID: 30900472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance.
    Zhang R; Wu L; Zhang HJ; Gao XJ; Pan XT; Wang XR; Ye H; Liu GH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12757-12762. PubMed ID: 33378024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood N-terminal Pro-brain Natriuretic Peptide and Interleukin-17 for Distinguishing Incomplete Kawasaki Disease from Infectious Diseases.
    Wu L; Chen Y; Zhong S; Li Y; Dai X; Di Y
    Indian Pediatr; 2015 Jun; 52(6):477-80. PubMed ID: 26121721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY; Ham EM; Kwon H; Kwak YH; Kim DK; Lee JH; Jung JH
    Am J Emerg Med; 2019 Mar; 37(3):468-471. PubMed ID: 29903669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Sep; 17(1):65. PubMed ID: 31533770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
    Lee SH; Song ES; Yoon S; Hong S; Cho HJ; Yang EM; Eom GH; Kang G; Cho YK
    Dis Markers; 2017; 2017():6263121. PubMed ID: 29358841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.